Annelienke van Hulst

141 Determinants for side effects 4 Dexamethasone-induced neurobehavioral problems (ΔSDQ≥5) Median (IQR) or n (%) OR 95%-CI n = 70 5.3 (4.0-8.4) 0.90 0.81-0.99 41 (58.6) 29 (41.4) 1.36 0.58-3.16 5 (3-9) 0.95 0.88-1.02 37 (32-45) 1.00 0.96-1.03 n = 70 34 (21-44) 0.99 0.96-1.02 61 (87.1) 9 (12.9) 1.57 0.40-6.22 63 (90) 7 (10) 0.83 0.23-3.07 58 (82.9) 12 (17.1) 0.70 0.26-1.91 n = 64 37 (33-41) 0.96 0.90-1.02 39 (35-46) 0.94 0.89-1.01 61 (87.1) 9 (12.9) 0.37 0.13-1.02 59 (93.7) 4 (6.3) 0.20 0.06-0.74 56 (88.9) 7 (11.1) 0.43 0.14-1.36 29 (48.4) 31 (51.7) 0.59 0.24-1.44 31 (54.4) 26 (45.6) 0.84 0.35-2.03 1 (1-2) 1.12 0.77-1.61 n = 70 44 (33-59) 1.02 1.00-1.05 69 (53-88) 1.06 1.03-1.08 21 (10-35) 1.11 1.06-1.16

RkJQdWJsaXNoZXIy MTk4NDMw